NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/04/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization22.43 mln
Float14.37 mln
Earnings Date11/18/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
2.08
Highly suspicious
Relative Strength
93
/ 100
Top performer
Debt / Equity
1.26
Elevated leverage
Pre-Tax Margin
-14%
Loss-making
ROE
-209
Deeply negative
Business Description
Biofrontera is a US-based company focused on bringing specialized skin care treatments to market. Its main product, Ameluz, is used alongside a proprietary lamp system to treat actinic keratosis, a condition where sun-damaged skin develops lesions that can become cancerous if left untreated. Founded in 2015 and operating out of Woburn, Massachusetts, the company works to make these treatments available to patients across the country.
